Scroll Top

Signs of Market Recovery in the MedTech Space

Guidepoint Qsight’s medical device market-level dataset has captured trends in multiple MedTech market segments.

  • Following the sharp drop at the beginning of the COVID-19 pandemic, U.S. medical device purchasing spend rebounded quickly in July 2020 back to pre-COVID-19 levels for all five market segments captured in our dataset.
  • Segments most subject to elective procedures experienced the biggest downfall, not only in April 2020 but also in January 2021, due to increased COVID-19 cases. 
  • Based on commentary from our proprietary panel of physicians, the easing of COVID-19 restrictions, increased vaccination rates, and working through backlogged procedures are all potential reasons for the bounce back in March 2021.
  • When looking at growth for each segment between 2019 Q1 and 2021 Q1, our healthcare facilities purchasing dataset reflects an increase of 2.6% ($15.1B to $15.5B), signaling towards market recovery.
  • All segments showed an increase in revenue from 2019 to 2021, except Orthopedics, likely due to the elective nature of their procedures, January holidays, increased COVID-19 infections, and inclement weather delaying procedures. 

The above is based on Qsight’s healthcare facilities purchasing dataset analyzing over $20B in annual spend from the top 25 players in medical devices across a panel of 2200+ distinct healthcare facilities and hospitals.

Post Created by: Shimul Sheth, Senior Quantitative Analyst, Guidepoint Qsight & Rain Li, Data Science Intern

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.